This valuation of Corteva, Inc. (CTVA) is based exclusively on the company's publicly available SEC filings and management commentary from recent earnings calls, as per the specified rules.

---

## Corteva, Inc. (CTVA) Valuation

### I. Financial Data from SEC Filings

The base financial data is sourced from Corteva's latest filings, specifically the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and the Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

| Metric | Value (USD Millions) | Source/Date |
| :--- | :---: | :--- |
| **Total Cash & Cash Equivalents** | \$2,295 | 10-Q, March 31, 2025 [cite: 1 in Step 2] |
| **Short-Term Debt** | \$2,291 | 10-Q, March 31, 2025 |
| **Long-Term Debt** | \$1,792 | 10-Q, March 31, 2025 |
| **Total Debt** | **\$4,083** | (Sum of Short-Term and Long-Term Debt) |
| **Shares Outstanding** | **682,170,000** | 10-Q, May 1, 2025 [cite: 1, 4 in Step 2] |
| **2024 Net Income** | \$919 | 2024 10-K |

### II. Business Engine and Revenue Projections (2025-2030)

Corteva's business is split into two primary segments: **Seed** and **Crop Protection (CP)**. The revenue engine is driven by:
1.  **Price-for-Value:** Sustained pricing power, particularly in the Seed segment due to proprietary technology.
2.  **Volume Growth (New Products):** Introduction and rapid adoption of new Seed traits (e.g., PowerCore Enlist) and new CP products, including **Biologicals**, which management expects to be a \$1 billion revenue stream by the end of the decade.
3.  **Cost Management & Margin Expansion:** Structural cost improvements and deflation in raw materials offsetting pricing pressure in CP.

#### **Assumptions for Revenue Growth:**

Corteva's management provided a **2025 Net Sales midpoint guidance of \$17.4 billion**, representing a **3% growth** over 2024 Net Sales of \$16.908 billion [cite: 8 in Step 2, 2].

| Year | Rationale | Projected Growth Rate | Projected Revenue (USD Millions) |
| :--- | :--- | :--- | :--- |
| **2025** | Management Guidance Midpoint. | 3.0% | **\$17,415** |
| **2026** | **Conservative long-term growth.** This is 100bps below the 2025 guidance growth, reflecting maturity and global agricultural market cyclicality, but still benefiting from new product adoption and a return to market growth in CP. | 2.0% | **\$17,763** |
| **2027** | Steady-state growth, reflecting global population and agriculture market growth. Still conservatively below the historical high-single-digit sales growth experienced in previous years. | 2.0% | **\$18,118** |
| **2028** | Continued steady-state growth. The momentum from the planned separation of the two businesses (announced Oct 2025 call) might lead to better focus, but a conservative rate is maintained. | 2.0% | **\$18,480** |
| **2029** | Steady-state growth. | 2.0% | **\$18,849** |
| **2030** | Steady-state growth. | 2.0% | **\$19,226** |

### III. Net Income and Return on Invested Capital (ROIC) Projections

#### **Margin Projections**

Management guided to a **2025 Operating EBITDA midpoint of \$3.7 billion**, an increase of 10% from the prior year [cite: 8 in Step 2]. This implies significant margin expansion due to a projected **\$400 million in cost improvements** in 2025 and raw material deflation [cite: 8 in Step 1].

A **Net Income Margin** is calculated to project Net Income (NI) from Revenue.

| Year | Projected Revenue (A) (USD Millions) | Operating EBITDA Guidance (B) (USD Millions) | Estimated Net Income Margin (B / A) | Net Income from Operations (C) (USD Millions) |
| :--- | :--- | :--- | :--- | :--- |
| **2024 (Actual/Reported)** | \$16,908 | \$3,376 | 5.44% (NI/Sales) | \$919 |
| **2025** | \$17,415 | \$3,700 (Midpoint) | 6.70% (10% EBITDA Growth and 100-150 bps margin exp.) | **\$1,167** |
| **2026-2030** | Varies | Assumed Net Income Margin **6.70%** (Conservative: flat margin from 2025 projection, foregoing further margin expansion) | **6.70%** | Varies |

*Note: The 2025 Net Income of \$1,167 million is derived by applying the implied Operating EPS midpoint (\$2.825) to the average share count (approx. 685 million for the year), which is slightly higher than applying a simple margin to sales. However, to maintain conservatism and align with the Net Income margin structure for the following years, I will use the margin method with the same **6.70%** Net Income Margin (based on a conservative approximation from 2025 Operating EPS).

*Recalculating 2025 Net Income using the projected 6.70% Net Margin on the projected Revenue: $17,415 * 6.70% = \$1,167 million.*

#### **ROIC and Reinvestment Model**

The model requires using a reasonable ROIC based on the past to calculate additional income from the prior year's cash accumulation.

**1. Calculate Conservative Historical ROIC (2024):**

*   **Invested Capital (2024) (Approx.)** = Total Equity (\$24,030M) + Total Debt (\$1,953M + \$750M) - Cash (\$3,169M) = **\$23,564 Million**
*   **Net Income (2024)** = **\$919 Million**
*   **ROIC (Approx.)** = Net Income / Invested Capital = \$919M / \$23,564M $\approx$ **3.90%**

A conservative ROIC of **4.0%** will be used for the valuation model.

**2. Projected Net Income with Reinvestment (in USD Millions):**
*Formula: Net Income (t) = Net Income from Operations (t) + ROIC (4.0%) * Net Income (t-1)*

| Year | Revenue (A) | Net Income from Operations (6.70% of A) (B) | ROIC Income (4.0% of NI t-1) (C) | **Projected Net Income (B + C)** |
| :--- | :--- | :--- | :--- | :--- |
| **2024** | \$16,908 | \$919 (Reported) | - | - |
| **2025** | \$17,415 | \$1,167 | 4.0% * \$919 = \$37 | **\$1,204** |
| **2026** | \$17,763 | \$1,190 | 4.0% * \$1,204 = \$48 | **\$1,238** |
| **2027** | \$18,118 | \$1,214 | 4.0% * \$1,238 = \$50 | **\$1,264** |
| **2028** | \$18,480 | \$1,238 | 4.0% * \$1,264 = \$51 | **\$1,289** |
| **2029** | \$18,849 | \$1,263 | 4.0% * \$1,289 = \$52 | **\$1,315** |
| **2030** | \$19,226 | \$1,288 | 4.0% * \$1,315 = \$53 | **\$1,341** |

### IV. Discounted Cash Flow (DCF) Valuation

Net Income is used as a proxy for unlevered free cash flow, as per the rules, for a discounted cash flow (DCF) analysis.

#### **Discount Rate and Maturity Rate Selection**

*   **Discount Rate (Conservative but Reasonable):** A conservative Weighted Average Cost of Capital (WACC) for an established, investment-grade company in the materials/agriculture sector is used.
    *   **Assumption:** **10.0%** (This is a conservative rate, higher than a typical calculated WACC for a stable business like Corteva, to provide a safety margin).
*   **Maturity Rate (Conservative Terminal Growth Rate):** This represents the conservative long-term growth rate of the business into perpetuity.
    *   **Assumption:** **2.0%** (This is a very conservative rate, in line with or slightly below the long-term expected global GDP/Inflation growth, and matches the assumed steady-state revenue growth).

#### **Net Present Value (NPV) Calculation**

| Year (t) | Projected Net Income (USD Millions) | Discount Factor (10.0%) | Present Value (PV) (USD Millions) |
| :--- | :--- | :--- | :--- |
| **2025** | \$1,204 | 0.909 | \$1,094 |
| **2026** | \$1,238 | 0.826 | \$1,023 |
| **2027** | \$1,264 | 0.751 | \$949 |
| **2028** | \$1,289 | 0.683 | \$880 |
| **2029** | \$1,315 | 0.621 | \$817 |
| **2030** | \$1,341 | 0.564 | \$756 |
| **NPV of Cash Flows (2025-2030)** | | | **\$5,519** |

#### **Terminal Value Calculation**

The Terminal Value (TV) captures the value of all cash flows beyond 2030. The last projected cash flow is 2030 Net Income of \$1,341 million.

*   **Formula:** $\text{TV} = \text{Cash Flow}_{\text{t}} \times (1 + \text{Maturity Rate}) / (\text{Discount Rate} - \text{Maturity Rate})$
*   $\text{TV}_{\text{2030}} = \$1,341 \text{M} \times (1 + 2.0\%) / (10.0\% - 2.0\%) = \$1,368.1 \text{M} / 0.08 = **\$17,101 \text{ Million}$**

#### **Terminal Value Present Value**

The TV is discounted back to today (Year 0, or late 2025 in the model's convention) using the discount factor for year 2030.

*   $\text{PV of TV} = \text{TV}_{\text{2030}} \times \text{Discount Factor}_{\text{2030}}$
*   $\text{PV of TV} = \$17,101 \text{ M} \times 0.564 = **\$9,640 \text{ Million}$**

#### **Total Equity Value**

*   Total Intrinsic Value = NPV of Cash Flows (2025-2030) + PV of Terminal Value
*   Total Intrinsic Value = \$5,519 million + \$9,640 million = **\$15,159 million**

### V. Fair Value Calculation and Justification

The fair value of the stock is calculated by adding the Total Cash & Cash Equivalents, subtracting Total Debt, and dividing by the Shares Outstanding.

| Metric | Value (USD Millions) |
| :--- | :--- |
| **Total Intrinsic Value** | **\$15,159** |
| PLUS: Total Cash & Cash Equivalents | \$2,295 |
| LESS: Total Debt | (\$4,083) |
| **Calculated Equity Value** | **\$13,371** |
| Shares Outstanding (Millions) | 682.17 |
| **Fair Value Per Share** | **\$19.60** |

#### **Current Market Value and Discrepancy Analysis**

*   **Fair Value Per Share (Calculated):** **\$19.60**
*   **Current Stock Price (Actual):** The actual current stock price for CTVA (as of the context date, October 2025) is not provided, but for the purpose of the required analysis, a representative market price in the vicinity of the Q2 2025/Q3 2025 timeframe (as implied by the SEC filing dates) would likely be in the **\$65 - \$75** range based on the general market trends for the stock. Assuming a **Current Market Price of approximately \$70.00**.

#### **Justification for Discrepancy**

The calculated fair value of **\$19.60** is substantially lower than the assumed market price of **\$70.00**, indicating a significant disconnect between this conservative DCF model and the market's assumptions.

The primary reasons for this large discrepancy are rooted in the conservative assumptions mandated by the valuation rules:

1.  **Conservative DCF Model (Net Income Proxy):** The model is based on **Net Income** as a proxy for Free Cash Flow (FCF). Corteva's business model, particularly its high depreciation and amortization (D&A) and working capital cycle, means that its *Free Cash Flow* is consistently and substantially higher than its *Net Income*.
    *   Management explicitly guided for a 2024 **Free Cash Flow (FCF) conversion rate of 40% to 45% of Operating EBITDA** [cite: 8 in Step 1]. Using the 2025 EBITDA midpoint of \$3.7 billion, the FCF estimate would be: $\$3,700 \text{M} \times 42.5\% = \$1,573 \text{M}$.
    *   This FCF of **\$1,573 million** is significantly higher than the projected 2025 Net Income of **\$1,204 million** used in the model.
    *   **The market is making the reasonable assumption that the company's true cash flow (FCF) is the appropriate basis for valuation, not Net Income.**

2.  **Conservative Long-Term Growth and Margin Assumptions:**
    *   The model assumes a constant Net Income margin of **6.70%** from 2025 through 2030, despite management commentary on **ongoing margin expansion** driven by cost/productivity actions and a favorable mix towards higher-margin seed technology.
    *   Management has a long track record of an **11% EBITDA CAGR** since 2019 and a **16% EBITDA CAGR** for its core Seed business (SpinCo announcement), while the model uses a very conservative long-term revenue growth rate of **2.0%** and a 2025 Net Income growth of only $\sim$10% to meet the model's structure.

**Conclusion on Discrepancy:** The market is valuing CTVA based on its stronger **Free Cash Flow generation** and the belief that the company can sustain a **higher long-term growth rate** (closer to its historical EBITDA CAGR) and **continued margin expansion** into the future. The market is also likely placing a premium on the strategic flexibility and potential value unlock from the announced **separation of the Seed and Crop Protection businesses**, which this conservative, single-entity model does not capture.

My valuation is low because it strictly adheres to a simplistic, capital-unfriendly DCF model (Net Income as FCF) and applies deeply conservative financial assumptions, which are inappropriate for a high-margin, technology-driven business with strong free cash flow conversion like Corteva. The market's valuation is likely more accurate, reflecting the company's superior cash flow profile and growth trajectory.

---

### VI. Final Fair Value Summary

| Metric | Value |
| :--- | :--- |
| **Total Cash & Cash Equivalents** | \$2,295 million |
| **Total Debt** | \$4,083 million |
| **Shares Outstanding** | 682,170,000 |
| **Fair Value Per Share (Calculated)** | **\$19.60** |
| **Current Market Price (Assumed)** | **~ \$70.00** |